Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients
- 29 March 2012
- journal article
- Published by Springer Nature in Biotechnology Letters
- Vol. 34 (7) , 1235-1241
Abstract
The presence of serum tumor markers, carbohydrate antigen 242 (CA242), carbohydrate antigen 199 (CA199), carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA), tumor-supplied group of factors (TSGF) and tumor necrosis factor-α (TNF-α), is closely associated with invasion and metastasis of many malignancies. The expression of these markers were measured in serum taken from 37 pancreatic cancer patients prior to treatment. Levels of CA242, CA199, CA125, CEA and TNF-α expression correlated with tumor size, clinical stage, tumor differentiation, lymph node and liver metastasis (P < 0.05). One month after cryosurgery, serum levels of these markers were significantly reduced compared with levels prior to cryosurgery (P < 0.05), whereas there was no significant difference was found between serum levels before and after chemotherapy (P > 0.05). Thus, cryosurgery is more effective than chemotherapy for decreasing CA242, CA199, CA125, CEA, TSGF and TNF-α serum levels in these patients.Keywords
This publication has 15 references indexed in Scilit:
- A pilot study on combination of cryosurgery and 125iodine seed implantation for treatment of locally advanced pancreatic cancerWorld Journal of Gastroenterology, 2008
- Surgery Insight: surgical management of pancreatic cancerNature Clinical Practice Oncology, 2007
- Cryosurgery for TumorsJournal of the American College of Surgeons, 2007
- Current Status of Surgery for Pancreatic CancerDigestive Surgery, 2007
- A Phase I/II Study of Combination Chemotherapy with Gemcitabine and 5-Fluorouracil for Advanced Pancreatic CancerJapanese Journal of Clinical Oncology, 2006
- A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinomaBritish Journal of Cancer, 2006
- Update on cryotherapy for prostate cancer in 2006Current Opinion in Urology, 2006
- Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer RegistryGut, 2005
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial CellsJournal of Biological Chemistry, 1998